Opexa Sells Stem Cell Technology To Novartis, Shares Skyrocket - Update

Opexa Sells Stem Cell Technology To Novartis, Shares Skyrocket - Update

  • Posted Friday, August 07, 2009 -
  • Share |
Shares of Opexa Therapeutics Inc. (OPXA) are on fire, rising as much as over 500% in intraday trading following news that its stem cell technology, which is in early preclinical development, has been acquired by Swiss pharmaceutical giant Novartis AG (NVS) in a deal exceeding $50 million not including royalties.view original article

Related News Items